{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:38:46Z","timestamp":1787009926673,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:p>Gallbladder cancer is a rare malignancy in most countries. The racial and sociodemographic factors associated with its incidence and survival are poorly defined. We aimed to investigate population-based gallbladder cancer incidence and survival trends on the basis of clinical characteristics and sociodemographic factors in the USA. Gallbladder cancer incidence and survival data from 2001 to 2012 were obtained from 18 registries of the Surveillance, Epidemiology, and End Results database. Incidence rates and Joinpoint trends were calculated by demographic subgroup. Survival trends were assessed using Cox proportional hazard models. A total of 7769 patients were identified. The overall gallbladder cancer incidence rates did not significantly change during the 2001\u20132012 period. Incidence rates were three times higher in Hispanics and 1.6 times higher in Blacks compared with Whites. Over the time period, incidence rates significantly increased among Blacks and decreased among Hispanics. Male sex [hazard ratio (HR): 1.10, 95% confidence interval (CI): 1.03\u20131.17], older age (HR: 1.73, 95% CI: 1.53\u20131.96), and single and divorced statuses (HR: 1.19, 95% CI: 1.09\u20131.30 and 1.12, 95% CI: 1.01\u20131.24) were independently associated with shorter overall survival, whereas higher education (HR: 0.89, 95% CI: 0.82\u20130.97) and higher income (HR: 0.89, 95% CI: 0.82\u20130.96) were associated with longer survival. Furthermore, overall survival has improved in all races\/ethnicities except for Hispanics and Blacks. The overall incidence rates for gallbladder cancer were stable during 2001\u20132012. Hispanics have the highest incidence rates, but the incidence rates in Blacks are on the rise.<\/jats:p>","DOI":"10.1097\/cej.0000000000000402","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T11:58:03Z","timestamp":1499169483000},"page":"1-9","source":"Crossref","is-referenced-by-count":43,"title":["The incidence rates and survival of gallbladder cancer in the USA"],"prefix":"10.1097","volume":"28","author":[{"given":"Veeravich","family":"Jaruvongvanich","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Hawaii, Honolulu, Hawaii"},{"name":"Department of Medicine, King Chulalongkorn Memorial Hospital, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Dong","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoetchai","family":"Peeraphatdit","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis R.","family":"Roberts","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230901","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1200\/JCO.2013.49.6489","article-title":"Marital status and survival in patients with cancer","volume":"31","author":"Aizer","year":"2013","journal-title":"J Clin Oncol"},{"key":"R2-20230901","doi-asserted-by":"crossref","first-page":"905","DOI":"10.5858\/2005-129-905-PCOTGA","article-title":"Papillary carcinomas of the gallbladder: analysis of noninvasive and invasive types","volume":"129","author":"Albores-Saavedra","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"R3-20230901","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1200\/JCO.2014.60.2219","article-title":"SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma","volume":"33","author":"Ben-Josef","year":"2015","journal-title":"J Clin Oncol"},{"key":"R4-20230901","doi-asserted-by":"crossref","first-page":"53668","DOI":"10.18632\/oncotarget.10696","article-title":"Impact of sex, age, and ethnicity\/race on the survival of patients with rectal cancer in the United States from 1988 to 2012","volume":"7","author":"Berger","year":"2016","journal-title":"Oncotarget"},{"key":"R5-20230901","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ctrv.2015.01.003","article-title":"Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy","volume":"41","author":"Bizama","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"R6-20230901","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/ijc.28161","article-title":"Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site","volume":"133","author":"Castro","year":"2013","journal-title":"Int J Cancer"},{"key":"R7-20230901","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1517\/14740338.5.1.117","article-title":"Is there a link between oestrogen therapy and gallbladder disease?","volume":"5","author":"Dhiman","year":"2006","journal-title":"Expert Opin Drug Saf"},{"key":"R8-20230901","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(81)90366-4","article-title":"Cholecystectomy and changing mortality from gallbladder cancer","volume":"2","author":"Diehl","year":"1981","journal-title":"Lancet"},{"key":"R9-20230901","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","article-title":"Gallbladder cancer: can newer insights improve the outcome?","volume":"27","author":"Dutta","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"key":"R10-20230901","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/bjc.2013.801","article-title":"S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma","volume":"110","author":"El-Khoueiry","year":"2014","journal-title":"Br J Cancer"},{"key":"R11-20230901","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0016-5085(99)70456-7","article-title":"Prevalence and ethnic differences in gallbladder disease in the United States","volume":"117","author":"Everhart","year":"1999","journal-title":"Gastroenterology"},{"key":"R13-20230901","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10552-006-0109-4","article-title":"Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997\u20132002","volume":"18","author":"Goodman","year":"2007","journal-title":"Cancer Causes Control"},{"key":"R14-20230901","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/jnci\/djq366","article-title":"Improved estimates of cancer-specific survival rates from population-based data","volume":"102","author":"Howlader","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"R15-20230901","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"R16-20230901","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1245\/s10434-006-9224-4","article-title":"Incidence pattern and survival for gallbladder cancer over three decades \u2013 an analysis of 10301 patients","volume":"14","author":"Kiran","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"R17-20230901","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/00008469-200308000-00004","article-title":"The recent decline in gallbladder cancer mortality in Europe","volume":"12","author":"Levi","year":"2003","journal-title":"Eur J Cancer Prev"},{"key":"R18-20230901","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s11605-010-1335-3","article-title":"National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis","volume":"14","author":"Mayo","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"R19-20230901","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1001\/jamaoto.2014.1671","article-title":"Survival outcomes in advanced laryngeal cancer","volume":"140","author":"Megwalu","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"R20-20230901","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.14694\/EdBook_AM.2014.34.e165","article-title":"A review of recent data in the treatment of gallbladder cancer: what we know, what we do, and what should be done","author":"M\u00fcller","year":"2014","journal-title":"Am Soc Clin Oncol Educ book"},{"key":"R21-20230901","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.juro.2012.11.153","article-title":"Sex disparities in cancer mortality: the risks of being a man in the United States","volume":"189","author":"Najari","year":"2013","journal-title":"J Urol"},{"key":"R23-20230901","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/j.1572-0241.2008.01949.x","article-title":"Racial disparities in cholecystectomy rates during hospitalizations for acute gallstone pancreatitis: a national survey","volume":"103","author":"Nguyen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R24-20230901","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10354-006-0346-x","article-title":"Gender and gallstone disease","volume":"156","author":"Novacek","year":"2006","journal-title":"Wien Med Wochenschrt"},{"key":"R25-20230901","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/ijc.21683","article-title":"Gallbladder cancer worldwide: geographical distribution and risk factors","volume":"118","author":"Randi","year":"2006","journal-title":"Int J Cancer"},{"key":"R26-20230901","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/modpathol.2011.68","article-title":"Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas","volume":"24","author":"Roa","year":"2011","journal-title":"Mod Pathol"},{"key":"R27-20230901","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1471-2407-13-242","article-title":"The effect of different dosing regimens of motesanib on the gallbladder: a randomized phase 1b study in patients with advanced solid tumors","volume":"13","author":"Rosen","year":"2013","journal-title":"BMC Cancer"},{"key":"R28-20230901","doi-asserted-by":"crossref","first-page":"156","DOI":"10.18632\/oncotarget.832","article-title":"). Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials","volume":"4","author":"Subbiah","year":"2013","journal-title":"Oncotarget"},{"key":"R30-20230901","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/000313481408000718","article-title":"Changing demographics in laparoscopic cholecystectomy performed in the United States: hospitalizations from 1998 to 2010","volume":"80","author":"Tucker","year":"2014","journal-title":"Am Surg"},{"key":"R31-20230901","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"New Engl J Med"},{"key":"R32-20230901","doi-asserted-by":"crossref","first-page":"29655","DOI":"10.1038\/srep29655","article-title":"Sex, race, and age disparities in the improvement of survival for gastrointestinal cancer over time","volume":"6","author":"Wan","year":"2016","journal-title":"Sci Rep"},{"key":"R33-20230901","doi-asserted-by":"crossref","first-page":"e3315","DOI":"10.1097\/MD.0000000000003315","article-title":"Association between race\/ethnicity and survival of melanoma patients in the United States Over 3 decades: a secondary analysis of SEER data","volume":"95","author":"Ward-Peterson","year":"2016","journal-title":"Medicine"},{"key":"R34-20230901","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/S0959-8049(03)00370-8","article-title":"Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968\u20131998","volume":"39","author":"Wood","year":"2003","journal-title":"Eur J Cancer"},{"key":"R36-20230901","first-page":"43","article-title":"Racial disparities in treatment and survival of patients with hepatocellular carcinoma in the United States","volume":"5","author":"Xu","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R37-20230901","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2014.161","article-title":"Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010","volume":"1","author":"Zeng","year":"2015","journal-title":"JAMA Oncol"},{"key":"R38-20230901","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1634\/theoncologist.2009-0302","article-title":"Current management of gallbladder carcinoma","volume":"15","author":"Zhu","year":"2010","journal-title":"Oncologist"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00008469-201901000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T20:05:54Z","timestamp":1693598754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00008469-201901000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000402","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}